Clinical Trial Update: Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on CAStem for severe COVID-19 with or without ARDS across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• CAStem

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: COVID-19, Acute Respiratory Distress Syndrome | Phase 1, Phase 2 | Status: UNKNOWN